Table 1.
Characteristics of the study group and control group.
| Demographic Data | |||
|---|---|---|---|
| Variable | Study Group (AIH) n = 25 (%) |
Control Group n = 20 (%) |
|
| 1. | Gender | ||
| Women | 22 (88%) | 18 (90%) | |
| Men | 3 (12%) | 2 (10%) | |
| 2. | Age [years] | ||
| Median (range) | 56 (23–80) | 43.5 (21–69) | |
| 3. | BMI [kg/m2] | ||
| Median (range) | 25.5 (18.7–37.1) | 21.0 (17–29) | |
| Clinical data | |||
| 4. | Duration of the disease [years] | ||
| Median (range) | 13 (1–25) | - | |
| 5. | Treatment | ||
| Steroids | 16 (64%) | - | |
| Immunosuppressants | 1 (4%) | - | |
| Steroids + Immunosuppressants | 8 (32%) | - | |
| 6. | Family history towards AIH | ||
| Negative | 19 (76%) | - | |
| Positive | 6 (24%) | - | |
| 7. | LC | 8(32%) | - |
| Non-LC | 17 (68%) | - | |
| 8. | Comorbidities | ||
| Yes * | 13 (52%) | 6 (30%) | |
| No | 12 (48%) | 13 (70%) | |
AIH—autoimmune hepatitis, BMI—body mass index, LC—liver cirrhosis. * including: nephrolithiasis, osteoporosis, bronchial asthma, arterial hypertension, diabetes, glaucoma, chronic heart failure.